These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
142 related articles for article (PubMed ID: 7640220)
1. Chromosome 11 allele imbalance and clinicopathological correlates in ovarian tumours. Gabra H; Taylor L; Cohen BB; Lessels A; Eccles DM; Leonard RC; Smyth JF; Steel CM Br J Cancer; 1995 Aug; 72(2):367-75. PubMed ID: 7640220 [TBL] [Abstract][Full Text] [Related]
2. Loss of constitutional heterozygosity on chromosome 11p in human ovarian cancer. Positive correlation with grade of differentiation. Kiechle-Schwarz M; Bauknecht T; Wienker T; Walz L; Pfleiderer A Cancer; 1993 Oct; 72(8):2423-32. PubMed ID: 8402459 [TBL] [Abstract][Full Text] [Related]
3. Refinement of two chromosome 11q regions of loss of heterozygosity in ovarian cancer. Davis M; Hitchcock A; Foulkes WD; Campbell IG Cancer Res; 1996 Feb; 56(4):741-4. PubMed ID: 8631007 [TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21. Tavassoli M; Steingrimsdottir H; Pierce E; Jiang X; Alagoz M; Farzaneh F; Campbell IG Br J Cancer; 1996 Jul; 74(1):115-9. PubMed ID: 8679443 [TBL] [Abstract][Full Text] [Related]
5. Loss of heterozygosity for chromosome 11 in adenocarcinoma of the stomach. Baffa R; Negrini M; Mandes B; Rugge M; Ranzani GN; Hirohashi S; Croce CM Cancer Res; 1996 Jan; 56(2):268-72. PubMed ID: 8542579 [TBL] [Abstract][Full Text] [Related]
6. Polymerase chain reaction allelotyping of human ovarian cancer. Osborne RJ; Leech V Br J Cancer; 1994 Mar; 69(3):429-38. PubMed ID: 8123469 [TBL] [Abstract][Full Text] [Related]
8. Deletion of chromosome 11p15, p12, q22, q23-24 loci in human prostate cancer. Dahiya R; McCarville J; Lee C; Hu W; Kaur G; Carroll P; Deng G Int J Cancer; 1997 Jul; 72(2):283-8. PubMed ID: 9219834 [TBL] [Abstract][Full Text] [Related]
9. Chromosomal localisation of two putative 11p oncosuppressor genes involved in human ovarian tumours. Viel A; Giannini F; Tumiotto L; Sopracordevole F; Visentin MC; Boiocchi M Br J Cancer; 1992 Dec; 66(6):1030-6. PubMed ID: 1360809 [TBL] [Abstract][Full Text] [Related]
10. Whole chromosome 17 loss in ovarian cancer. Tavassoli M; Ruhrberg C; Beaumont V; Reynolds K; Kirkham N; Collins WP; Farzaneh F Genes Chromosomes Cancer; 1993 Nov; 8(3):195-8. PubMed ID: 7509629 [TBL] [Abstract][Full Text] [Related]
11. Definition and refinement of a region of loss of heterozygosity at 11q23.3-q24.3 in epithelial ovarian cancer associated with poor prognosis. Gabra H; Watson JE; Taylor KJ; Mackay J; Leonard RC; Steel CM; Porteous DJ; Smyth JF Cancer Res; 1996 Mar; 56(5):950-4. PubMed ID: 8640783 [TBL] [Abstract][Full Text] [Related]
12. Deletion of chromosome 11p13-11p15.5 sequences in invasive human ovarian cancer is a subclonal progression factor. Vandamme B; Lissens W; Amfo K; De Sutter P; Bourgain C; Vamos E; De Grève J Cancer Res; 1992 Dec; 52(23):6646-52. PubMed ID: 1423308 [TBL] [Abstract][Full Text] [Related]
13. Characterization of chromosome 9 in human ovarian neoplasia identifies frequent genetic imbalance on 9q and rare alterations involving 9p, including CDKN2. Schultz DC; Vanderveer L; Buetow KH; Boente MP; Ozols RF; Hamilton TC; Godwin AK Cancer Res; 1995 May; 55(10):2150-7. PubMed ID: 7743516 [TBL] [Abstract][Full Text] [Related]
14. Ovarian cancer has frequent loss of heterozygosity at chromosome 12p12.3-13.1 (region of TEL and Kip1 loci) and chromosome 12q23-ter: evidence for two new tumour-suppressor genes. Hatta Y; Takeuchi S; Yokota J; Koeffler HP Br J Cancer; 1997; 75(9):1256-62. PubMed ID: 9155043 [TBL] [Abstract][Full Text] [Related]
15. Identification of a 6-cM minimal deletion at 11q23.1-23.2 and exclusion of PPP2R1B gene as a deletion target in cervical cancer. Pulido HA; Fakruddin MJ; Chatterjee A; Esplin ED; Beleño N; Martinez G; Posso H; Evans GA; Murty VV Cancer Res; 2000 Dec; 60(23):6677-82. PubMed ID: 11118052 [TBL] [Abstract][Full Text] [Related]
16. High frequency of chromosome 9 deletion in ovarian cancer: evidence for three tumour-suppressor loci. Devlin J; Elder PA; Gabra H; Steel CM; Knowles MA Br J Cancer; 1996 Feb; 73(4):420-3. PubMed ID: 8595153 [TBL] [Abstract][Full Text] [Related]
17. Poor correlation with loss of heterozygosity on chromosome 17p and p53 mutations in ovarian cancers. Sakamoto T; Nomura N; Mori H; Wake N Gynecol Oncol; 1996 Nov; 63(2):173-9. PubMed ID: 8910623 [TBL] [Abstract][Full Text] [Related]
18. Chromosome 11q22.3-q25 LOH in ovarian cancer: association with a more aggressive disease course and involved subregions. Launonen V; Stenbäck F; Puistola U; Bloigu R; Huusko P; Kytölä S; Kauppila A; Winqvist R Gynecol Oncol; 1998 Nov; 71(2):299-304. PubMed ID: 9826475 [TBL] [Abstract][Full Text] [Related]
19. Frequent loss of heterozygosity on chromosomes 6q, 11, and 17 in human ovarian carcinomas. Lee JH; Kavanagh JJ; Wildrick DM; Wharton JT; Blick M Cancer Res; 1990 May; 50(9):2724-8. PubMed ID: 2328498 [TBL] [Abstract][Full Text] [Related]
20. Identification of a 1300 kilobase deletion unit on chromosome 7q31.3 in invasive epithelial ovarian carcinomas. Edelson MI; Scherer SW; Tsui LC; Welch WR; Bell DA; Berkowitz RS; Mok SC Oncogene; 1997 Jun; 14(24):2979-84. PubMed ID: 9205105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]